This document discusses drug advertisements and outlines objectives for analyzing them critically. It defines advertising and notes that drug purchases are not made solely by buyers. Advertisements can inform doctors of new drugs but sometimes make misleading claims. The document lists components of good ads and improper practices like highlighting only benefits. It provides guidelines from an industry group on appropriate ad content and complaints processes. Key information to consider in ads includes generic/brand names, ingredients, dosage, and references. Claims should be backed by efficacy, safety and pharmacokinetic data.